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Background: Testosterone levels are decreased in diabetic patients and recent studies have suggested that high-normal 
fasting glucose is a risk factor for cardiovascular disease. To further elucidate the relationship between plasma glucose 
and testosterone, we investigated the association between fasting plasma glucose (FPG) and endogenous sex hormones 
(serum total testosterone, sex hormone binding globulin, estradiol, and the ratio of testosterone to estradiol) in non-
diabetic and pre-diabetic men.
Methods: This study included 388 men (age ≥ 40 years) who visited the health promotion center of a university hospital 
from May 2007 to August 2008. The subjects were divided into quartiles based on their FPG levels and correlation and 
multiple linear regression analyses were performed. Q1 (65 mg/dL ≤ FPG < 88 mg/dL), Q2 (88 mg/dL ≤ FPG < 94 mg/dL), 
Q3 (94 mg/dL ≤ FPG < 100 mg/dL) and Q4 (100 mg/dL ≤ FPG < 126 mg/dL).
Results: FPG was independently, inversely associated with total testosterone in the non-diabetic population after adjusting 
for age, body mass index, smoking, and alcohol consumption (β = -0.082, P < 0.01). Among the quartiles, subjects in the 
high-normal FPG groups (Q2, Q3, and Q4 with FPG ≥ 88 mg/dL) had signifi cantly decreased testosterone levels when 
compared with subjects in the normal FPG group (Q1 with FPG < 88 mg/dL, P < 0.005). Sex hormone binding globulin, 
estradiol and the ratio of testosterone to estradiol were not correlated with FPG.
Conclusion: Our study indicates that high-normal fasting glucose levels are associated with decreased testosterone levels 
in non-diabetic and pre-diabetic men.
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INTRODUCTION
Testosterone is associated with bone mineral density, body 
composition, mood, aggression, cognitive function, and sexual 
function.1) Several studies have reported decreased testosterone 
levels with metabolic syndrome, visceral obesity, atherosclerosis, 
and type 2 diabetes mellitus (DM) in men.2-6) Studies have also 
suggested a relationship between fasting glucose and androgen 
levels in patients with diabetes, metabolic syndrome, coronary 
artery disease, and erectile dysfunction.7-9) Hyperinsulinemia and 
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excess leptin may aff ect the suppression of sex hormone binding 
globulin (SHBG) activity and plasma testosterone.10,11) However, 
there is currently no data about these relationships in non-diabetic 
men with high-normal glucose levels or in pre-diabetic men.
Our previous study revealed that subjects with high-normal 
glucose levels were characterized by a high incidence of arterial 
stiff ness.12) Th is suggests that fasting plasma glucose (FPG), even 
within the normal range, may aff ect androgen levels. Furthermore, 
this approach would be valuable because FPG can be easily 
measured in primary care sett ings and is a reversible risk factor. 
In this study we assessed the relationship between FPG, total 
testosterone, and SHBG as well as the testosterone to estradiol 




We recruited 430 men (age ≥ 40 years) who visited the 
health promotion center of a university hospital from May 2007 
to August 2008. Twenty-eight subjects with a history of taking 
anti-diabetes medication, eight with stroke or cardiovascular 
disease, one with extremely low FPG levels (50-65 mg/dL), 
and five subjects who had previously taken testosterone and 
glucocorticoid medications were excluded. Aft er these exclusions, 
388 subjects were included in this study. Th e Institutional Review 
Board of Gangnam Severance Hospital, Yonsei University College 
of Medicine approved this study and informed consent was 
obtained from each participant.
According to FPG levels, subjects with normal FPG and 
impaired fasting glucose (IFG) levels were divided into quartiles: 
Q1 (65 mg/dL ≤ FPG < 88 mg/dL), Q2 (88 mg/dL ≤ FPG < 
94 mg/dL), Q3 (94 mg/dL ≤ FPG < 100 mg/dL), and Q4 (100 
mg/dL ≤ FPG < 126 mg/dL). Anthropometric measurements 
were used to calculate the body mass index (BMI). A questionnaire 
was used to obtain information about each subject’s medical 
history and lifestyle, such as smoking habits and alcohol 
consumption. Blood pressure was measured at rest aft er a period 
of fi ve minutes. Aft er an overnight fast, serum glucose levels were 
measured using a Hitachi 7600-110 chemistry auto-analyzer 
(Hitachi, Tokyo, Japan). Total testosterone, SHBG, and estradiol 
levels were measured by electrochemiluminescence (Modular 
E-170; Roche Diagnostic Systems, Basel, Switzerland).
2. Statistical Analysis
SAS ver. 9.1 (SAS Inc., Cary, NC, USA) was utilized for 
statistical analyses. Mean values of clinical characteristics were 
compared among the four subject groups using one-way analysis 
of variance for continuous variables and the chi-squared test 
for categorical variables. Pearson’s correlation coefficients were 
calculated to evaluate the relationships between testosterone, ratio 
of testosterone to estradiol, SHBG, and other clinical variables. 
Multiple linear regression analysis was performed aft er adjusting 
for age, BMI, smoking, and alcohol consumption in order to 
identify any independent associations between testosterone 
and FPG. P-values less than 0.05 were considered statistically 
signifi cant.
Table 1. Clinical and metabolic characteristics of study participants categorized by fasting plasma glucose into four quartiles.
Variables Q1 (n = 83) Q2 (n = 95) Q3 (n = 94) Q4 (n = 116) P-value
Mean fasting glucose (mg/dL) 83.6 (2.5) 90.1 (1.6) 96.3 (1.9) 108.1 (6.9) < 0.001
Age (y) 42.4 (1.7) 46.5 (1.0) 49.5 (1.9)  52.4 (2.0) < 0.001
Body mass index (kg/m2) 24.3 (3.4) 24.1 (2.4) 24.3 (2.7)  25.0 (2.6) 0.12
Systolic blood pressure (mm Hg) 123.2 (15.4) 122.5 (13.6) 125.9 (13.1)  125.5 (15.5) 0.28
Diastolic blood pressure (mm Hg) 77.1 (9.0) 76.9 (8.4) 79.9 (8.1)  79.1 (8.9) 0.04
Smoking* (%) 36.1 27.4 30.9 22.4 0.19
Alcohol† (%) 71.1 71.4 65.6 50.0 0.003
Data are shown as the mean ± standard deviation or a percentage (%).  P-values were calculated by analysis of variance and the χ2-test.
*Smokers were defi ned as current smokers. †Alcohol consumption ≥ once per week.
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RESULTS
The clinical characteristics of the 388 men enrolled in 
this study are shown in Table 1. The mean glucose level of the 
IFG group (Q4) was 108.1 ± 6.9 mg/dL. The mean glucose 
level of normoglycemic subjects was 90.2 ± 5.7 mg/dL. Mean 
fasting glucose level, age, diastolic blood pressure, and alcohol 
consumption differed between quartiles. The mean BMI of all 
subjects was within the overweight range. The mean systolic 
blood pressure was in the pre-hypertensive stage, while the 
diastolic blood pressure was in the normotensive stage as defi ned 
by the Joint National Committ ee on Evaluation, and Treatment 
of High Blood Pressure guidelines.
FPG was inversely correlated with total testosterone (Table 
2, Figure 1). Aft er adjustment for age, BMI, smoking, and alcohol 
consumption, FPG was independently associated with total 
testosterone levels in the non-diabetic and pre-diabetic men (β = 
-0.082, P < 0.01) (Table 3). Total testosterone was signifi cantly 
decreased in non-diabetic subjects with high-normal glucose and 
IFG levels. In particular, subjects in the high FPG groups (above 
88 mg/dL) showed decreased testosterone levels aft er adjusting 
for age, BMI, smoking, and alcohol consumption (Figure 2). 
SHBG, estradiol, and the ratio of testosterone to estradiol were 
not correlated with FPG.
Table 2. Correlation between endogenous sex hormones and various parameters.
T SHBG E2 T/E2
r P-value r P-value r P-value r P-value
Fasting glucose -0.198 < 0.01 -0.246 0.48 -0.661 0.81  0.008 0.50
Age -0.283  0.08 -0.280 0.60  0.081 0.95 -0.017 0.36
Body mass index -0.383 < 0.01 -0.883 0.01 -0.395 0.51 -0.010 0.22
Systolic blood pressure  0.004  0.92 -0.005 0.97 -0.015 0.95  0.001 0.65
Diastolic blood pressure -0.061  0.39 -0.209 0.34 -0.228 0.53 -0.001 0.84
Smoking  0.661  0.29  0.109 0.57  0.329 0.35 -0.009 0.84
Alcohol -0.326  0.58  0.091 0.96 -0.160 0.62  0.005 0.92
Coeffi cients (r) and P-values were calculated by Pearson’s correlation analysis.
T: testosterone, SHBG: sex hormone binding globulin, E2: estradiol.
Figure 1. The relationship between fasting plasma glucose (FPG) 
and total testosterone. The values of total testosterone were 
inversely correlated with FPG in middle-aged, non-diabetic Korean 
men (r = -0.198, P < 0.01). There was no subject with FPG level less 
than 80 mg/dL.
Table 3. Results of multiple linear regression analysis performed 
to assess the independent relationship between testosterone and 




Fasting plasma glucose -0.082 0.028 < 0.01
Age -0.058 0.156  0.71
Body mass index -0.412 0.100 < 0.01
The multiple linear regression analysis model adjusted for age, 
body mass index, smoking, and alcohol consumption (R2 = 0.304, 
adjusted R2 = 0.298).
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DISCUSSION
In this study, FPG was negatively and independently 
associated with total testosterone in non-diabetic Korean men. 
Interestingly, high-normal glucose and IFG levels were associated 
with a signifi cant decrease in serum total testosterone. FPG levels 
can be measured easily in the outpatient clinic sett ing, allowing 
for early intervention. Th erefore, we suggest that FPG levels could 
be an important marker for men’s health risk assessment in non-
diabetic patients.
In previous studies, testosterone was shown to be negatively 
correlated with insulin, leptin, and the homeostasis model 
assessment of insulin resistance.13) Hyperinsulinemia may 
suppress SHBG synthesis and decrease serum testosterone, 
thereby regulating the levels of luteinizing hormone. Studies have 
also suggested that hyperinsulinemia may suppress testosterone 
synthesis in the testis.10,11,14,15)
According to recent treatment guidelines, testosterone 
replacement therapy is recommended when total testosterone 
levels are below 8 nmol/L, while individuals with serum levels 
above 12 nmol/L are not categorized as having sexual dysfunction 
and are thus not candidates for replacement therapy. Although 
the cohort in this study had normal testosterone levels with 
no abnormal clinical signs indicating hypogonadism, glycemic 
levels should be carefully monitored considering the association 
between hypogonadal symptoms and diabetes.6,16)
In our study, estradiol levels were not correlated with FPG.8) 
Yasui et al.17) and Dunajska et al.18) reported a correlation between 
estradiol and FPG, although the subjects in their studies were 
Japanese and differences in demographics could account for 
the variation. Other lifestyle factors such as smoking were not 
associated with testosterone levels, and this fi nding was supported 
in a study by Halmenschlager et al.19)
Our study has some limitations with respect to extrapolating 
generalizations from our results. The narrow age range is useful 
since it suggests that men in this range should monitor their 
glycemic levels carefully. However, the results of this study 
cannot be applied to older individuals. Further research is 
needed to elucidate the relationship between testosterone and 
plasma glucose in older populations. Second, since insulin levels 
were not measured in our cohort, we cannot comment on the 
effect of insulin on testosterone metabolism. Finally, a recent 
study showed that up to 5% of subjects with IFG appear to 
have diabetes according to the 2-hour glucose tolerance test.20) 
Th erefore, true-DM and IFG groups were not demarcated in the 
glucose tolerance test, implying that some individuals in the IFG 
group may actually have had DM.
Although this study has some limitations, we demonstrated 
that FPG is negatively and independently associated with total 
testosterone in non-diabetic, middle-aged Korean men, and may 
be a useful marker to control glycemic levels in order to prevent 
decreased testosterone levels in this population.
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